Scientists from ChristianaCare’s Gene Editing Institute have found that a mutation unique to certain cancer tumors may serve as a protial signal for usingCRISPR gene editing safely to convert DNA that makes cancer cells resitant to treatment without affecitn the healthy cells.
Their study was published in an article titled “Kinetics of Nuclear Uptake and Site-Specific DNA Cleavage during CRISPR-Directed Gene Editing in Solid Tumor Cells”Molecular Cancer Research
CRISPR gene editing solution could used as an effective adjuvant therapy for patients with advanced lung cancer, particulary in cases where the current standard of care has failed and may be resitstant to standard chemotherapy.
